Ep. 37: Breakthrough in Early-Stage Cancer Detection with Dawn Mattoon, PhD
In this episode, VibeCast host Ray Dogum speaks with Dawn Mattoon, PhD, CEO of Mercy BioAnalytics, about Breakthroughs in Early-Stage Cancer Detection. ------------------------------------------------------------------------ Key moments 00:00:06 - Introduction to Vibecast 00:00:43 - Background and Journey into Biotech 00:05:51 - Mercy BioAnalytics' Mission 00:06:51 - Transition to CEO 00:09:08 - Series A Financing and Investors 00:16:54 - The Importance of Velocity in Cancer Screening 00:18:07 - Challenges and Frictions in Accessing Screening Technology 00:19:57 - Addressing Friction in the Screening Process through Blood-Based Tests 00:24:04 - Partnerships and Collaboration in Cancer Screening Guest Bio: Dr. Dawn Mattoon is the Chief Executive Officer at Mercy Bioanalytics. She brings nearly 20 years of experience in the biotechnology industry and has held leadership positions in R&D, Strategy, and General Management for a series of exceptional companies including Invitrogen, Life Technologies, Thermo Fisher, and Cell Signaling Technology. Prior to joining Mercy, Dr. Mattoon served as the Senior Vice President for Clinical Diagnostics at Quanterix, where she led the development and commercialization of the company’s first two FDA authorized diagnostic tests for COVID-19, and received Breakthrough Device designations from the FDA for diagnostic tests in Alzheimer’s Disease and Multiple Sclerosis. She has developed and commercialized products across a range of proteomic and genomic technologies and is thrilled by the opportunity to bring the highly innovative Mercy Halo diagnostic test portfolio to patients. Dr. Mattoon earned her Ph.D. in Genetics with a focus in signal transduction from Yale University, where she also completed her postdoctoral fellowship. Dawn and her husband of 27 years, Scott, are ten-year residents of greater Boston where they enjoy hiking, paddling, and occasional visits from their children Ryland (Junior, Davidson College), and Avery (Sophomore, Emory University). Guest Links: Linkedin: https://www.linkedin.com/in/dawn-mattoon-792511a/ Mercy BioAnalytics Linkedin: https://www.linkedin.com/company/mercy-bioanalytics/ Mercy BioAnalytics Website: https://mercybio.com/
About VibeCast VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation. Guests include biotech founders, regulatory experts, drug development executives, blockchain technologists, web3 community builders, patient community advocates, and many other Vibe Bio community members seeking to accelerate the development of breakthrough treatments.
Follow Vibe Bio's Socials:
Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.
